Maria Jesus Blanco-Pillado

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Neuroactive steroids and their methods of use
- Patent number 12,264,177
- Issue date Apr 1, 2025
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neuroactive steroids and their methods of use
- Patent number 12,252,509
- Issue date Mar 18, 2025
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neuroactive steroids and their methods of use
- Patent number 11,999,765
- Issue date Jun 4, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C7, C12, and C16 substituted neuroactive steroids and their methods...
- Patent number 11,993,628
- Issue date May 28, 2024
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neuroactive steroids and their methods of use
- Patent number 11,970,514
- Issue date Apr 30, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neuroactive steroids and their methods of use
- Patent number 11,912,738
- Issue date Feb 27, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating CNS disorders
- Patent number 11,718,642
- Issue date Aug 8, 2023
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neuroactive steroids and compositions thereof
- Patent number 11,643,434
- Issue date May 9, 2023
- SAGE THERAPEUTICS, INC.
- Francesco G. Salituro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neuroactive steroids substituted in position 10 with a cyclic group...
- Patent number 11,634,453
- Issue date Apr 25, 2023
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C17, C20, and C21 substituted neuroactive steroids and their method...
- Patent number 11,396,525
- Issue date Jul 26, 2022
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
- Publication number 20250171492
- Publication date May 29, 2025
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20250154194
- Publication date May 15, 2025
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
9(11)-UNSATURATED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20250136638
- Publication date May 1, 2025
- SAGE THERAPEUTICS, INC.
- Francesco G. SALITURO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS...
- Publication number 20250092084
- Publication date Mar 20, 2025
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEUTERATED POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE TH...
- Publication number 20240417423
- Publication date Dec 19, 2024
- SAGE THERAPEUTICS, INC.
- Maria-Jesus Blanco-Pillado
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUROACTIVE STEROIDS SUBSTITUTED IN POSITION 10 WITH A CYCLIC GROUP...
- Publication number 20240376144
- Publication date Nov 14, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20240368214
- Publication date Nov 7, 2024
- SAGE THERAPEUTICS, INC.
- Maria-Jesus Blanco-Pillado
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20240343756
- Publication date Oct 17, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20240336648
- Publication date Oct 10, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20240309042
- Publication date Sep 19, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATING CNS DISORDERS
- Publication number 20240300996
- Publication date Sep 12, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF
- Publication number 20240279268
- Publication date Aug 22, 2024
- SAGE THERAPEUTICS, INC.
- Francesco G. Salituro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20240239835
- Publication date Jul 18, 2024
- SAGE THERAPEUTICS, INC.
- Francesco G. Salituro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
- Publication number 20240150393
- Publication date May 9, 2024
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
- Publication number 20240101592
- Publication date Mar 28, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS SUBSTITUTED IN POSITION 10 WITH A CYCLIC GROUP...
- Publication number 20240051987
- Publication date Feb 15, 2024
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20230322846
- Publication date Oct 12, 2023
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20230322847
- Publication date Oct 12, 2023
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20230322848
- Publication date Oct 12, 2023
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20230322849
- Publication date Oct 12, 2023
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYP46A1 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20230312522
- Publication date Oct 5, 2023
- Steven Mischke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
- Publication number 20230303616
- Publication date Sep 28, 2023
- SAGE THERAPEUTICS, INC.
- Francesco G. Salituro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATING CNS DISORDERS
- Publication number 20230257415
- Publication date Aug 17, 2023
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF
- Publication number 20230250129
- Publication date Aug 10, 2023
- Bingsong Han
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF
- Publication number 20230250128
- Publication date Aug 10, 2023
- Francesco G. Salituro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20230183288
- Publication date Jun 15, 2023
- SAGE THERAPEUTICS, INC.
- Francesco G. Salituro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHOD...
- Publication number 20230116347
- Publication date Apr 13, 2023
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
- Publication number 20230085354
- Publication date Mar 16, 2023
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
- Publication number 20230046825
- Publication date Feb 16, 2023
- SAGE THERAPEUTICS, INC.
- Maria Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS...
- Publication number 20230021308
- Publication date Jan 19, 2023
- SAGE THERAPEUTICS, INC.
- Albert Jean Robichaud
- C07 - ORGANIC CHEMISTRY

Maria Jesus Blanco-Pillado

Person

Patents Grantslast 30 patents

Neuroactive steroids and their methods of use

Neuroactive steroids and their methods of use

Neuroactive steroids and their methods of use

C7, C12, and C16 substituted neuroactive steroids and their methods...

Neuroactive steroids and their methods of use

Neuroactive steroids and their methods of use

Compositions and methods for treating CNS disorders

Neuroactive steroids and compositions thereof

Neuroactive steroids substituted in position 10 with a cyclic group...

C17, C20, and C21 substituted neuroactive steroids and their method...

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

9(11)-UNSATURATED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS...

DEUTERATED POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE TH...

NEUROACTIVE STEROIDS SUBSTITUTED IN POSITION 10 WITH A CYCLIC GROUP...

POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

COMPOUNDS FOR TREATING CNS DISORDERS

NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

NEUROACTIVE STEROIDS SUBSTITUTED IN POSITION 10 WITH A CYCLIC GROUP...

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

CYP46A1 INHIBITORS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

COMPOUNDS FOR TREATING CNS DISORDERS

NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF

NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHOD...

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS...